Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Rivera-Egea, Rocio
- Mossetti, Laura
Grupos
Abstract
Purpose The use of testicular sperm is confined to patients with azoospermia, but there is evidence to support its use in males with poor semen parameters and/or previous intracytoplasmic sperm injection (ICSI) failures with ejaculated spermatozoa. We compared the aneuploidy rate and quality between embryos derived from ICSI cycles with ejaculated sperm (EJ-ICSI) and those from ICSI cycles using testicular spermatozoa (TT-ICSI) within the same couple. Methods Retrospective study of 27 couples who first underwent an EJ-ICSI cycle that did not result in a livebirth and afterwards a TT-ICSI cycle. Only the two closer cycles of each couple were included. Preimplantation genetic test for aneuploidies (PGT-A) was performed in both ICSI cycles and classic parameters of embryo quality were assessed until blastocyst-stage. Results A total of 375 embryos from 54 ICSI cycles were evaluated. Aneuploidy rate was measured by two different parameters. Patients undergoing TT-ICSI presented a similar aneuploidy rate as EJ-ICSI group: 30.7% (23.4-38.0) vs 26.8% (18.1-35.5) per inseminated oocytes (P>0.05), and 76.2% (66.2-86.2) vs 72.1% (59.1-85.2) per the total number of biopsied embryos (P>0.05), respectively. Further, the good-quality blastocyst rate per correctly fertilized oocyte was significantly higher in TT-ICSI group (33.6% (30.4-36.9)) than EJ-ICSI group (24.2% (20.3-28.0)) (P<0.001). Conclusions Switching to testicular sperm for ICSI yielded better-quality blastocysts without affecting the chromosomal load of the embryos in non-azoospermic couples with a previous unsuccessful ICSI using ejaculated sperm. This strategy is a good option for couples seeking a livebirth who do not want to use donor sperm.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Datos de la publicación
- ISSN/ISSNe:
- 1058-0468, 1573-7330
- Tipo:
- Article
- Páginas:
- 2275-2285
- Factor de Impacto:
- 1,109 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS SPRINGER/PLENUM PUBLISHERS
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- Aneuploidy rate; Ejaculated sperm; ICSI; Male factor; Testicular sperm
Proyectos asociados
Evalución del tratamiento clínico en varones con oligospermia severa, fallos de ICSI y elevada fragmentación de ADN mediante el uso de espermatozoides testiculares.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
PI18/00325 . INSTITUTO DE SALUD CARLOS III . 2019
Contrato PFIS: Predoctorales de formación en investigación en salud.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
FI19/00051 . INSTITUTO DE SALUD CARLOS III . 2020
Influencia del virus del papiloma humano (VPH) en semen sobre los resultados reproductivos y lavado de semen con heparinasa como opción terapéutica en la infección.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
PI21/00322 . INSTITUTO DE SALUD CARLOS III . 2022
Resonancia Magnética y Biomarcadores de imagen para el mapeo, localización de focos de espermatogénesis y guiado de las biopsias testiculares en pacientes con azoospermia no obstructiva.
Investigador Principal: JOSÉ REMOHÍ GIMÉNEZ
PI21/00424 . INSTITUTO DE SALUD CARLOS III . 2022
Análisis del biomarcador epigenético en el semen involucrado en el riesgo de autismo en la descendencia.
Investigador Principal: ANA VICTORIA MARCO HERNÁNDEZ
2103-FIVI-022-NG . 2021
Cita
Hervas I,Gil M,Rivera R,Navarro A,Mossetti L,Garrido N. Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk. J Assist Reprod Genet. 2022. 39. (10):p. 2275-2285. IF:3,100. (2).